AVROBIO, Inc. (AVRO)
(Delayed Data from NSDQ)
$19.01 USD
+0.48 (2.59%)
Updated May 3, 2019 04:00 PM ET
After-Market: $19.01 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Tectonic Therapeutic, Inc. [AVRO]
Reports for Purchase
Showing records 1 - 20 ( 114 total )
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Winding Down and Exploring Alternatives; D/G to Neutral
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
More Consistent Results for Cystinosis Gene Therapy
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
Gaucher Going Well, Seeing Cystinosis in the Second Half
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Tectonic Therapeutic, Inc.
Industry: Medical - Biomedical and Genetics
ASGCT 2023 Abstract Roundup For Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D